Instacart reported second-quarter earnings that exceeded Wall Street estimates, buoyed by the strongest order growth since 2022. Revenue rose 11% from a year earlier to $914 million, topping the $897 million consensus, while net income more than doubled to $116 million, or $0.41 a share—three cents above analyst expectations. Gross transaction value reached $9.08 billion, also ahead of forecasts. The grocery-delivery company said it expects third-quarter gross transaction value of $9.0 billion to $9.15 billion and adjusted EBITDA of $260 million to $270 million, both above market estimates. The guidance comes as outgoing Chief Executive Officer Fidji Simo prepares to leave later this month; Chief Business Officer Chris Rogers has been tapped to succeed her. Investors welcomed the results and outlook, pushing the shares up roughly 11% in early Friday trading. Benchmark upgraded the stock to Buy with a $67 price target, and Needham, Citi, Barclays and others raised their targets to the mid-$60s, citing accelerating growth and rising demand from smaller grocers that rely on Instacart’s platform to compete with Walmart and Amazon.
$INSM -UBS raises Insmed target to $133 from $124 Buy -RBC raises target to $120 from $108 Outperform - $INVE -B. Riley lowers Identiv target to $6 from $6.50 Buy -Craig Hallum lowers target to $5 from $6 Buy -
$IAS -Raymond James lowers Integral Ad Services target to $11 from $13 Outperform -Barclays raises target to$10 from $9 = Weight - $ICUI -Raymond James lowers ICU Medical target to $180 from $187 Strong Buy -
$HLLY -Benchmark downgrades Holley to Hold from Buy $4 target - $HP -RBC raises Helmerich & Payne target to $24 from $23 Sector Perform - $HRTX -Needham lowers Heron Therapeutics target to $3 from $4 Buy - $HUBS -Citi lowers HubSpot target to $650 from $700 Buy -